Plasma and Myocardial miRNomes Similarities and Differences during Cardiac Remodelling and Reverse Remodelling in a Murine Model of Heart Failure with Preserved Ejection Fraction

被引:0
|
作者
Thibodeau, Sara-eve [1 ]
Labbe, Emylie-Ann [1 ]
Walsh-Wilkinson, Elisabeth [1 ]
Morin-Grandmont, Audrey [1 ]
Arsenault, Marie [1 ]
Couet, Jacques [1 ]
机构
[1] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Grp Rech Valvulopathies, Quebec City, PQ G1V 4G5, Canada
关键词
mouse; heart failure; myocardial recovery; reverse remodelling; cardiac hypertrophy; microRNA; preclinical model; MICRORNAS; PHENOTYPE; LIFE;
D O I
10.3390/biom14080892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome characterised by multiple risk factors touching various organs outside the heart. Using a murine HFpEF model, we studied cardiac reverse remodelling (RR) after stopping the causing metabolic-hypertensive stress (MHS; Angiotensin II [AngII] and a high-fat diet [HFD]) after 28 days and introducing voluntary exercise (VE) for four more weeks. We measured the effects of MHS and RR on the plasma and myocardial microRNA (miR) profile (miRNome) to characterise better cardiac and non-cardiac responses to HFpEF-inducing risk factors and their reversibility. AngII alone, the HFD or the MHS caused cardiac hypertrophy (CH), left ventricular (LV) concentric remodelling and left atrial enlargement in females. Only AngII and the MHS, but not HFD, did in males. After RR, CH, LV concentric remodelling and atrial enlargement were normalised. Among the 25 most abundant circulating miRs, 10 were modulated by MHS. Plasma miRNomes from AngII, HFD or MHS mice shared 31 common significantly modulated miRs (24 upregulated and 7 downregulated), suggesting that the response of organs producing the bulk of those circulating miRs was similar even for seemingly different stress. In the LV, 19 out of 25 most expressed miRs were modulated. RR restored normality for the plasma miRNome but not for the LV miRNome, which remained mostly unchanged. Our results suggest that abnormalities persist in the myocardium of the HFpEF mice and that the normalisation of circulatory markers may be falsely reassuring after recovery.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] MYOCARDIAL LIPID ACCUMULATION AND CARDIAC REMODELLING IN HEART FAILURE WITH REDUCED AND PRESERVED EJECTION FRACTION
    Mahmod, Masliza
    Pal, Nikhil
    Holloway, Cameron
    Ferreira, Vanessa
    Dass, Sairia
    Francis, Jane
    Rider, Oliver
    Karamitsos, Theodoros
    Ashrafian, Houman
    Neubauer, Stefan
    HEART, 2015, 101 : A24 - A25
  • [2] Vascular remodelling in a mouse model of heart failure with preserved ejection fraction
    Sanhueza-Olivares, Fernanda
    Valenzuela-Arce, Francisca
    Calle-Chalco, Ximena
    Silva, David
    Munoz-Cordova, Felipe
    Mella-Torres, Andrea
    Ortega-Munoz, Angelica
    Troncoso, Mayarling F.
    Munoz-Rodriguez, Claudia
    de la Fuente, Francisco Pino
    Guerrero-Moncayo, Alejandra
    Hernandez, Alejandra
    Hill, Joseph A.
    Castro, Pablo F.
    Gabrielli, Luigi
    Lavandero, Sergio
    Chiong, Mario
    JOURNAL OF PHYSIOLOGY-LONDON, 2025,
  • [3] Prognostic value of left atrial reverse remodelling in heart failure with preserved ejection fraction
    Sun, Yuxi
    Fu, Qiang
    Tse, Gary
    Bai, Lin
    Liu, Jiani
    He, Hongyan
    Zhao, Shuang
    Tse, Mimi
    Liu, Ying
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (02) : 132 - 140
  • [4] Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction
    Gomez-Garre, Dulcenombre
    Luisa Gonzalez-Rubio, Ma
    Munoz-Pacheco, Paloma
    Caro-Vadillo, Alicia
    Aragoncillo, Paloma
    Fernandez-Cruz, Arturo
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (09) : 903 - 912
  • [5] Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction
    Hohendanner, Felix
    Messroghli, Daniel
    Bode, David
    Blaschke, Florian
    Parwani, Abdul
    Boldt, Leif-Hendrik
    Heinzel, Frank R.
    ESC HEART FAILURE, 2018, 5 (02): : 211 - 221
  • [6] The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
    Franssen, C.
    Gonzalez Miqueo, A.
    NETHERLANDS HEART JOURNAL, 2016, 24 (04) : 259 - 267
  • [7] The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
    C. Franssen
    A. González Miqueo
    Netherlands Heart Journal, 2016, 24 : 259 - 267
  • [8] Left ventricular remodelling and carotid hemodynamics in heart failure with preserved ejection fraction
    Cabac-Pogorevici, I. Irina
    Revenco, V.
    Jitari, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 169 - 169
  • [9] Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fraction
    Furquim, Silas Ramos
    Bocchi, Edimar Alcides
    Lira, Maria Tereza Sampaio de Sousa
    Wanderley Jr, Mauro Rogerio de Barros
    de Marchi, Daniel Catto
    Maciel, Pamela Camara
    Zimerman, Andre
    Ramires, Felix Jose Alvarez
    Nastari, Luciano
    Biselli, Bruno
    Chizzola, Paulo Roberto
    Munhoz, Robinson Tadeu
    Fernandes, Fabio
    Ayub-Ferreira, Silvia Moreira
    ESC HEART FAILURE, 2025,
  • [10] LEFT ATRIAL REMODELLING AND ATRIOVENTRICULAR COUPLING IN A CANINE MODEL OF EARLY HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Zakeri, Rosita
    Moulay, Gilles
    Chai, Qiang
    Ogut, Ozgur
    Hussain, Saad
    Takahama, Hiroyuki
    Lu, Tong
    Wang, Xiao-Li
    Linke, Wolfgang
    Lee, Hon-Chi
    Redfield, Margaret
    HEART, 2015, 101 : A109 - A110